• Home
  • Sitemap
  • Favorite
  • Admin
  • Korean
Pipeline
Lemonex is developing cancer immunotherapeutics, antibody therapeutics and gene therapeutics based on next-generation innovative
modular drug delivery technology and biosensor technology. We especially focus on the development of therapeutics to treat cancers,
intractable diseases
Cancer Immunotherapy & Targeted Cancer Therapy
PipelineTypeIndicationResearchPre-clinicalClinical Phase
LEM-TA201Nanobio-RobotHCC
LEM-AB701MAntibodySolid Tumor
LEM-AB702MCytokineSolid Tumor
LEM-AB703MAntibody + Cytokine Solid Tumor
LEM-AB801MmRNASolid Tumor
LEM-OT501Synthetic DrugGynecologic cancer
Intractable Diseases
PipelineTypeIndicationResearchPre-clinicalClinical Phase
LEM-S401MsiRNAAtopic Dermatitis
LEM-S402MsiRNAHypertrophic scar